Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodica P Bunaciu

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Biotechnology Progress|February 17, 2015
A 3D in situ cell counter reveals that breast tumor cell (MDA-MB-231) proliferation rate is reduced by the collagen matrix densityBeum Jun Kim, Shuting Zhao, Rodica P Bunaciu, et al.
FEBS Open Bio|November 14, 2015
Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expressionHolly A Jensen, Harmony B Yourish, Rodica P Bunaciu, et al.
Leukemia & Lymphoma|July 10, 2010
Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cellsSatyaprakash Nayak, Miaoqing Shen, Rodica P Bunaciu, et al.
Experimental Cell Research|March 21, 2009
Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cellsJames Smith, Rodica P Bunaciu, Gudrun Reiterer, et al.
Plos One|June 13, 2014
Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blastsHolly A Jensen, Rodica P Bunaciu, Christopher N Ibabao, et al.
Plos One|August 20, 2015
6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia CellsRodica P Bunaciu, Holly A Jensen, Robert J MacDonald, et al.
Leukemia & Lymphoma|March 24, 2018
Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cellsRobert J MacDonald, Rodica P Bunaciu, Victoria Ip, et al.
Plos One|April 5, 2013
The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cellsHolly A Jensen, Lauren E Styskal, Ryan Tasseff, et al.
Leukemia & Lymphoma|July 12, 2011
Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cellsMiaoqing Shen, Rodica P Bunaciu, Johanna Congleton, et al.
Leukemia & Lymphoma|December 21, 2018
Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AMLRodica P Bunaciu, Robert J MacDonald, Holly A Jensen, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Biotechnology Progress|February 17, 2015
A 3D in situ cell counter reveals that breast tumor cell (MDA-MB-231) proliferation rate is reduced by the collagen matrix densityBeum Jun Kim, Shuting Zhao, Rodica P Bunaciu, et al.
FEBS Open Bio|November 14, 2015
Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expressionHolly A Jensen, Harmony B Yourish, Rodica P Bunaciu, et al.
Leukemia & Lymphoma|July 10, 2010
Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cellsSatyaprakash Nayak, Miaoqing Shen, Rodica P Bunaciu, et al.
Experimental Cell Research|March 21, 2009
Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cellsJames Smith, Rodica P Bunaciu, Gudrun Reiterer, et al.
Plos One|June 13, 2014
Retinoic acid therapy resistance progresses from unilineage to bilineage in HL-60 leukemic blastsHolly A Jensen, Rodica P Bunaciu, Christopher N Ibabao, et al.
Plos One|August 20, 2015
6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia CellsRodica P Bunaciu, Holly A Jensen, Robert J MacDonald, et al.
Leukemia & Lymphoma|March 24, 2018
Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cellsRobert J MacDonald, Rodica P Bunaciu, Victoria Ip, et al.
Plos One|April 5, 2013
The Src-family kinase inhibitor PP2 rescues inducible differentiation events in emergent retinoic acid-resistant myeloblastic leukemia cellsHolly A Jensen, Lauren E Styskal, Ryan Tasseff, et al.
Leukemia & Lymphoma|July 12, 2011
Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cellsMiaoqing Shen, Rodica P Bunaciu, Johanna Congleton, et al.
Leukemia & Lymphoma|December 21, 2018
Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AMLRodica P Bunaciu, Robert J MacDonald, Holly A Jensen, et al.
Pageof 3